Advertisement
Advertisement
RNAZ
TransCode Therapeutics, Inc. Common Stock
1.69
USDSponsored
+0.04
+2.42%
Sep 25, 15:59 UTC -4
Closed
After-Market
1.70
+0.01
+0.30%
TransCode Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 28.70M |
| Beta | 1.16 |
| Earnings Per Share (EPS) | -52.37 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | -2.36% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -875.35% |
| Current Ratio | 1.97% |
| Free Cash Flow | -10.38M |
